MARKET

CHEK

CHEK

Check Cap
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.030
+0.095
+10.15%
After Hours: 1.030 0 0.00% 19:56 09/22 EDT
OPEN
0.9300
PREV CLOSE
0.9351
HIGH
1.070
LOW
0.9300
VOLUME
1.36M
TURNOVER
--
52 WEEK HIGH
4.490
52 WEEK LOW
0.2430
MARKET CAP
99.30M
P/E (TTM)
-2.9657
1D
5D
1M
3M
1Y
5Y
Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before t...
PR Newswire · 09/01 12:30
Check-Cap Tweets 'We are hiring in Israel! We are looking for innovative & passionate talents to join us in our effort to help decrease the incidence of #CRC worldwide through the development of a patient-friendly prep-free test...'
https://twitter.com/CheckCap_/status/1432327591797694467?s=20
Benzinga · 08/30 13:03
Check-Cap European Patent Register Doc For Co.'s 'POSITION ESTIMATION OF IMAGING CAPSULE IN GASTROINTESTINAL TRACT'
https://register.epo.org/application?number=EP14807239&tab=main
Benzinga · 08/10 19:15
HC Wainwright & Co. Maintains Buy on Check-Cap, Lowers Price Target to $3
HC Wainwright & Co. analyst Yi Chen maintains Check-Cap (NASDAQ:CHEK) with a Buy and lowers the price target from $4 to $3.
Benzinga · 08/09 10:36
Check-Cap EPS beats by $0.11
Check-Cap (NASDAQ:CHEK): Q2 GAAP EPS of $0.06 beats by $0.11. Cash and cash equivalents, restricted cash and short-term bank deposits as of June 30, 2021 were $29.3 million, compared with
Seekingalpha · 08/05 13:10
Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update
ISFIYA, , /PRNewswire/ --  (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan, the first and only patient-friendly, preparation-free screening test to detect pol...
PR Newswire - PRF · 08/05 12:30
We Think Check-Cap (NASDAQ:CHEK) Can Afford To Drive Business Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Simply Wall St. · 07/01 06:12
Check-Cap Shares Are Trading Lower On Capital Raise Of $35M To Support C-Scan Development
Benzinga · 06/30 15:32
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CHEK. Analyze the recent business situations of Check Cap through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CHEK stock price target is 2.500 with a high estimate of 3.000 and a low estimate of 2.000.
EPS
Institutional Holdings
Institutions: 38
Institutional Holdings: 4.93M
% Owned: 5.12%
Shares Outstanding: 96.40M
TypeInstitutionsShares
Increased
3
17.35K
New
8
4.27M
Decreased
7
220.36K
Sold Out
8
209.07K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.30%
Pharmaceuticals & Medical Research
-0.11%
Key Executives
Chairman/Director
Steven Hanley
Chief Executive Officer
Alex Ovadia
Chief Financial Officer
Mira Rosenzweig
Chief Technology Officer
Yoav Kimchy
Vice President - Operations
Joshua Belkar
Vice President
Hanit Brenner-lavie
Vice President
Israel Hershko
Vice President - Research & Development
Boaz Shpigelman
Independent Director
Clara Ezed
Independent Director
Mary Jo Gorman
Independent Director
XiangQian Lin
Independent Director
Yuval Yanai
No Data
About CHEK
Check-Cap is a Israel-based clinical-stage medical diagnostics company developing. The Company develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.

Webull offers kinds of Check Cap Ltd stock information, including NASDAQ:CHEK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHEK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CHEK stock methods without spending real money on the virtual paper trading platform.